[CONSOLIDATION_METHOD_TITLE] [CONSOLIDATION_METHOD]
Related Companies
[]
Related Funds
[]
English
oda_MaterialEventDisclosureGeneralAbstract|
Material Event Disclosure General
oda_UpdateAnnouncementFlag|
Update Notification Flag
Hayır (No)
oda_CorrectionAnnouncementFlag|
Correction Notification Flag
Hayır (No)
oda_DateOfThePreviousNotificationAboutTheSameSubject|
Date Of The Previous Notification About The Same Subject
-
oda_DelayedAnnouncementFlag|
Postponed Notification Flag
Hayır (No)
oda_AnnouncementContentSection|
Announcement Content
oda_ExplanationSection|
Explanations
oda_ExplanationTextBlock|

-Unofficial Translation-

Registration of SMA Drug named as "Spinraza" on behalf of our Company in our country was disclosed on 30.11.2023 ( https://www.kap.org.tr/en/Bildirim/1083111 ).

Alternative Reimbursement Agreement has been signed between Sosyal Security Institution of Türkiye ("SGK") and Gen İlaç ve Sağlık Ürünleri Sanayi ve Ticaret A.Ş. ("GEN") regarding this drug on 15.05.2024.

The effective date of the Agreement is 15.05.2024, and the agreement will end with the supply to SGK of the number of drugs specified in the agreement. It is expected that the contribution of this agreement to 2024 total sales of our company would be approximately TL 1.700.000.000 (One Billion Seven Hundred Million)